LOS ANGELES, CALIFORNIA - JUNE 13: Elon Musk speaks onstage at the Elon Musk in Conversation with Todd Howard panel during E3 2019 at the Novo Theatre on June 13, 2019 in Los Angeles, California. (Photo by Charley Gallay/Getty Images for E3/Entertainment Software Association)
Tesla and SpaceX CEO, Elon Musk, confirms on Twitter that he will be visiting Germany not as a tourist or for leisure, but in monitoring the company's efforts in the battle against COVID-19 with their RNA or ribonucleic acid printers that will help in producing a vaccine against the global pandemic. Tesla works with CureVac in using an RNA Printer that will contribute to the Novel coronavirus vaccine production.
Elon Musk, confirms that he will be traveling to the country of Germany this week, particularly to the company's biggest production plant, Gigafactory Berlin, to check on its sideline with CureVac. Musk confirmed his affiliation and efforts against the COVID-19 on a tweet posted on July 2.
Musk's trip to Germany will primarily focus on the vaccine and will only sideline with Tesla's progress on its innovations. Health concerns primarily drive the CEO's priorities. In a series of tweets Musk has replied to, he states his growing concern for 'false positive' COVID-19 cases that involved and tried Tesla employees.
Tesla, as a side project, is building RNA microfactories for CureVac & possibly others— Elon Musk (@elonmusk) July 2, 2020
One particular Tesla employee tested positive and caught the coronavirus at home and not from work, as Musk clarified. This case made Musk take actions for his employee's sake, who fell seriously ill with the virus. The Tesla CEO assured that his employee is well-taken care of in the hospital and checked on with the patient's wife. Musk further clarified that there were no deaths in the 'false positive' results of the COVID-19 tests.
One person at Tesla (out of 60,000) was hospitalized in serious condition (he caught cov2 at home, not work), no deaths. I called his wife & Hayward hospital to make sure he was getting the right treatment, but which he was. — Elon Musk (@elonmusk) August 30, 2020
He attributed this growing concern to the FDA's fast approval of certain testing methods but did not blame the federal agency.
Musk's Germany Announcement
Pranay Pathole (@PPathole) then took the conversation to another direction by asking the RNA factories' progress with CureVac, quoting the CEO's July tweet.
That & Giga Berlin are why I’m headed to Germany this week. Conversations with Harvard epidemiology confirmed that a high-speed RNA printer has potential be helpful for vaccines & cures in many areas. — Elon Musk (@elonmusk) August 30, 2020
To which Musk answered to confirm and announce his departure for Germany within this week to check on the Gigafactory Berlin. Presumably, the so-called 'RNA Factory' is located within Tesla's European plant, focusing itself on its efforts in vaccine production alongside its motor vehicle works.
According to Musk, Harvard's epidemiology considers RNA factories to have more speed and potential to procure a vaccine apart from current methods. CureVac and Tesla's partnership already resulted in a 'joint patent' RNA bioreactor that will revolutionize the field of medicine, according to Electrek.
RNA and COVID-19 Vaccines: Why is it Revolutionary?
TUBINGEN, GERMANY - MARCH 15: A label of the German biotech firm CureVac seen next to their headquarters on March 15, 2020 in Tubingen, Germany. According to German media outlet Welt am Sonntag U.S. President Donald Trump is seeking exclusive access for the United States to a potential coronavirus vaccine under development by CureVac. The issue is causing diplomatic ripples with the German government, which wants a potential vaccine to be available for Europe and other countries as well, not just for the United States. (Photo by Matthias Hangst/Getty Images)
Tesla and CureVac's partnership is considered an advancing feat in medicine as a different kind of cure will enter the market once it produces its promises. The RNA, also known as ribonucleic acid, is a macromolecule closely related to human DNA.
Sometimes, RNAs carry virus genetic codes that greatly differs from the DNA. CureVac has found a way to stabilize this molecule and turn it into a virus-fighting substance that is key to warding off COVID-19. Tesla will fix the slight hiccup of CureVac, which is mass production and availability of highly technological equipment that will fast track and help with the extensive labor process of RNA production.
Elon Musk's travel to Germany may potentially announce a breakthrough in the field of the COVID-19 vaccine. Tesla and CureVac's collaboration efforts may come into fruition in the form of highly innovative RNAs that will fight off the Novel coronavirus and impede its growing dangers.
